![JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania](https://www.mdpi.com/jcm/jcm-09-03826/article_deploy/html/images/jcm-09-03826-g001-550.jpg)
JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
![QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004 QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004](https://www.cdc.gov/mmwr/preview/mmwrhtml/figures/m548qsf.gif)
QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004
![Median serum prostate specific antigen (PSA) levels (ng/ml) in patients... | Download Scientific Diagram Median serum prostate specific antigen (PSA) levels (ng/ml) in patients... | Download Scientific Diagram](https://www.researchgate.net/publication/276885709/figure/fig2/AS:571341929709569@1513229939487/Median-serum-prostate-specific-antigen-PSA-levels-ng-ml-in-patients-receiving.png)
Median serum prostate specific antigen (PSA) levels (ng/ml) in patients... | Download Scientific Diagram
![SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and](https://minio.scielo.br/documentstore/1677-6119/jVxLkMSNXSmzhDyDd34Kgvd/97855423eadaa475aa2bff26d9ae03085ce47923.jpg)
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
![PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/251be2484ab726805c25860ba5917364701380f4/2-Table1-1.png)
PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar
![New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients | Imaging Technology News New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients | Imaging Technology News](http://www.itnonline.com/sites/default/files/Low-Res_Graphical%20Abstract%20Ng.jpg.png)
New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients | Imaging Technology News
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less. Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.](https://d3i71xaburhd42.cloudfront.net/bbc5bbcef53a29466addccfb1a86dca2e6a5abe5/2-Table1-1.png)
Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.
![Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep22050/MediaObjects/41598_2016_Article_BFsrep22050_Fig1_HTML.jpg)